<html>
<head>PUBMED IDs for RIOK3</head>
<body bgcolor='#C5F0F2'><h1>RIOK3</h1><a href='https://pubmed.ncbi.nlm.nih.gov/19050074/'>Genomic alterations link Rho family of GTPases to the highly invasive phenotype of pancreas cancer.</a> December 4  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19557502/'>RIOK3 interacts with caspase-10 and negatively regulates the NF-kappaB signaling pathway.</a> March 5  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20053773/'>Global methylation pattern of genes in androgen-sensitive and androgen-independent prostate cancer cells.</a> March 23  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/24807708/'>RIOK3 is an adaptor protein required for IRF3-mediated antiviral type I interferon production.</a> August 26  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25486436/'>Hypoxic regulation of RIOK3 is a major mechanism for cancer cell invasion and metastasis.</a> December 15  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25865883/'>RIOK3-mediated phosphorylation of MDA5 interferes with its assembly and attenuates the innate immune response.</a> January 9  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/27856519/'>Featured Article: Transcriptional landscape analysis identifies differently expressed genes involved in follicle-stimulating hormone induced postmenopausal osteoporosis.</a> November 19  2016<br></body></html>
